Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenue        
Customer revenue $ 0 $ 15,569 $ 6 $ 37,665
Collaboration revenue 0 3,951 47 3,846
Total revenue 0 19,520 53 41,511
Operating expenses        
Research and development (446) 9,595 1,523 37,347
General and administrative 3,581 6,839 11,145 14,526
Asset impairment 0 14,893 0 14,893
Total operating expenses 3,135 31,327 12,668 66,766
Loss from operations (3,135) (11,807) (12,615) (25,255)
Other income        
Interest income 169 549 610 1,396
Grant income 0 0 0 3,612
Other income 79 506 636 288
Net loss (2,887) (10,752) (11,369) (19,959)
Other comprehensive income loss:        
Foreign currency translation 120 (204) (343) (159)
Unrealized gain (loss) on available-for-sale securities 0 2 (1) 74
Comprehensive loss $ (2,767) $ (10,954) $ (11,713) $ (20,044)
Net loss per share        
Basic (in dollars per share) $ (2.19) $ (8.7) $ (8.84) $ (18.33)
Diluted (in dollars per share) $ (2.19) $ (8.7) $ (8.84) $ (18.33)
Weighted average number of common shares outstanding        
Basic (in shares) 1,320 1,236 1,285 1,089
Diluted (in shares) 1,320 1,236 1,285 1,089